 |
 |
| |
 |
May 1, 2009 |
| |
BioActor and Ferrer sign Collaboration Agreement on Bonolive, an innovative bone health agreement. |
| |
Details |
| |
|
|
October 17, 2008 |
| |
BioActor receives ERA-SME grant for clinical validation of the use of Olive Polyphenols for Bone Health |
| |
Hyperlink |
| |
|
|
January
15, 2007 |
| |
BioActor receives ERA-SME grant for clinical validation of the use of Olive Polyphenols for Bone Health |
| |
Hyperlink
|
| |
|
|
December
1, 2005 |
| |
BioActor
and Jaeckering sign Joint Development & Marketing Agreement on wheat |
| |
Hyperlink |
| |
|
|
November
14, 2005 |
| |
BioActor and INRA sign Licence Agreement on Olive Polyphenols and Bone Health. |
| |
Hyperlink |
| |
|
|
September
22, 2005 |
| |
BioActor
will present at the Flanders Biotech Forum that will take place
on November 14, 2005 in Osaka, Japan |
| |
|
| |
|
|
March
8, 2005 |
| |
BioActor
and CSIC signed an exclusive license for hypertension lowering
peptides. BioActor has taken a world-wide exclusive license
of CSIC's patent and know-how relating to hypertension lowering
bioactive peptides. BioActor intends to use this technology
for the development of novel dietary supplements and functional
foods that target cardiovascular health. The CSIC technology
offers superior benefits in terms of bioactivity, manufacturing
cost and absence of side effects. |
| |
|
| |
|
|
|
